• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估系统性溶栓治疗缺血性脑卒中急性期运动活动和止血系统状态的前瞻性试点研究。

PROSPECTIVE PILOT STUDY TO ASSESS MOTOR ACTIVITY AND THE STATE OF THE HEMOSTASIS SYSTEM IN THE ACUTE PERIOD OF ISCHEMIC STROKE DURING SYSTEMIC THROMBOLYTIC THERAPY.

机构信息

POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE.

出版信息

Wiad Lek. 2021;74(6):1307-1311.

PMID:34159909
Abstract

OBJECTIVE

The aim: To investigate changes in motor activity and indicators of the state of the hemostasis system in the acute period of ischemic stroke during systemic thrombolytic therapy and without its use.

PATIENTS AND METHODS

Materials and methods: We examined 26 male and female patients with a clinical diagnosis of ischemic stroke, who were hospitalized on the first day of the disease to the neurological departments. Patients were divided into 2 groups: group 1-patients who underwent systemic thrombolytic therapy (sTLT) (n=11), group 2-patients who did not receive sTLT (n=15). To compare the coagulogram parameters, 12 healthy patients were examined (control group). Examination of patients was performed on the 1st and 14th day of the disease (clinical examination, assessment of motor activity, coagulation test). Stroke severity was determined by the overall score of the National Institutes of Health Stroke Scale.

RESULTS

Results: The average age of patients in group 1 - 60.1±8.2 years old, in group 2 -61.3±5.5 years old. The number of points on the NIHSS scale in group 1 was 8.8±1.13 on 1st day and 3.7±0.79 on 14th day (p<0.05), in group 2 -5.7±0,94 on the 1st day and 3.1±0.93 on the 14th day(p<0.05). The results of the study of the coagulogram indicate a significantly higher level of soluble fibrin-monomer complexes on the 1st day on the 14th day of the ischemic stroke.

CONCLUSION

Conclusions: In the acute period of ischemic stroke changes in the hemostasis system reflected the direction of the selected therapy. The use of systematic thrombolytic therapy in ischemic stroke led to a more severe decrease in stroke severity on the NIHSS scale, a significant increase in Barthel index.

摘要

目的

研究急性缺血性脑卒中患者在接受和不接受系统性溶栓治疗期间运动活动和止血系统状态指标的变化。

患者和方法

我们检查了 26 名男性和女性患者,他们的临床诊断为缺血性脑卒中,在疾病的第一天被送往神经科病房。患者被分为 2 组:组 1-接受系统性溶栓治疗(sTLT)的患者(n=11),组 2-未接受 sTLT 的患者(n=15)。为了比较凝血谱参数,我们检查了 12 名健康患者(对照组)。在疾病的第 1 天和第 14 天对患者进行检查(临床检查、运动活动评估、凝血试验)。脑卒中严重程度由国立卫生研究院脑卒中量表的总分确定。

结果

组 1 的平均年龄为 60.1±8.2 岁,组 2 为 61.3±5.5 岁。组 1 的 NIHSS 量表评分第 1 天为 8.8±1.13,第 14 天为 3.7±0.79(p<0.05),组 2 第 1 天为 5.7±0.94,第 14 天为 3.1±0.93(p<0.05)。凝血谱研究结果表明,在缺血性脑卒中的第 14 天,可溶性纤维蛋白单体复合物的水平明显升高。

结论

在急性缺血性脑卒中期间,止血系统的变化反映了所选择治疗的方向。在缺血性脑卒中中使用系统性溶栓治疗导致 NIHSS 评分上脑卒中严重程度显著降低,Barthel 指数显著增加。

相似文献

1
PROSPECTIVE PILOT STUDY TO ASSESS MOTOR ACTIVITY AND THE STATE OF THE HEMOSTASIS SYSTEM IN THE ACUTE PERIOD OF ISCHEMIC STROKE DURING SYSTEMIC THROMBOLYTIC THERAPY.评估系统性溶栓治疗缺血性脑卒中急性期运动活动和止血系统状态的前瞻性试点研究。
Wiad Lek. 2021;74(6):1307-1311.
2
[Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].[在真实世界临床实践中使用瑞维立沙进行缺血性卒中静脉溶栓治疗:一项开放标签、前瞻性、多中心、非干预性研究IVT-AIS-R的中期结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(3. Vyp. 2):33-37. doi: 10.17116/jnevro202112103133.
3
[The state of microcirculation and platelet hemostasis in patients with ischemic stroke after systemic thrombolytic therapy].
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3. Vyp. 2):39-42. doi: 10.17116/jnevro20181183239-42.
4
[Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke].[缺血性卒中早期恢复期患者认知功能缺损的恢复动态]
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):26-32. doi: 10.17116/jnevro202112111126.
5
[Platelet hemostasis in patients with ischemic stroke after systemic thrombolytic therapy].[全身溶栓治疗后缺血性脑卒中患者的血小板止血功能]
Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(3 Pt 2):28-30. doi: 10.17116/jnevro20161163228-30.
6
[Systemic thrombolytic therapy of ischemic stroke in diabetes mellitus type 2 and hyperglycemia].2型糖尿病和高血糖患者缺血性卒中的全身溶栓治疗
Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(12. Vyp. 2):36-40. doi: 10.17116/jnevro201611612236-40.
7
Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.颈内动脉远端闭塞患者对动脉内及静脉联合动脉内溶栓治疗的反应
Stroke. 2002 Jul;33(7):1821-6. doi: 10.1161/01.str.0000020363.23725.67.
8
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
9
[Analysis of influencing factors of neurological function recovery and cerebral hemorrhage transformation after intravenous thrombolysis in patients with acute ischemic stroke].[急性缺血性脑卒中患者静脉溶栓后神经功能恢复及脑出血转化的影响因素分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1340-1345. doi: 10.3760/cma.j.cn121430-20200713-00517.
10
Contemporary utilization patterns and outcomes of thrombolytic administration for ischemic stroke among patients with cancer.癌症患者缺血性卒中溶栓治疗的当代应用模式及结局
Int J Stroke. 2021 Feb;16(2):150-162. doi: 10.1177/1747493019895709. Epub 2019 Dec 22.

引用本文的文献

1
Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients.血清脑源性神经营养因子水平和血栓形成类型可预测缺血性脑卒中患者急性期的认知障碍。
Neurol Res Int. 2023 Mar 15;2023:5578850. doi: 10.1155/2023/5578850. eCollection 2023.